ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Dogwood Therapeutics Inc

Dogwood Therapeutics Inc (DWTX)

2.645
-0.035
(-1.31%)
Closed November 26 4:00PM
2.645
0.00
(0.00%)
After Hours: 7:02PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
2.645
Bid
2.38
Ask
2.74
Volume
11,119
2.55 Day's Range 2.82
1.62 52 Week Range 5.29
Previous Close
2.68
Open
2.65
Last Trade
3
@
2.74
Last Trade Time
Average Volume (3m)
128,550
Financial Volume
$ 29,781
VWAP
2.6784

DWTX Latest News

Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

- IMC-2 treatment, dosed as valacyclovir 750 mg + celecoxib 200 mg twice daily, demonstrated clinically meaningful reduction in Long-COVID related fatigue and sleep disturbance as compared to...

Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

- Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) formed in October by combination of Virios Therapeutics, Inc. and Pharmagesic (Holdings) Inc., 100% parent company of Wex Pharmaceuticals, Inc. (the...

Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024

ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)

Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million to fund operations and advance Phase 2b Halneuron®...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.87549.43502824861.773.0281.761926912.59906828CS
4-2.255-46.02040816334.94.91.62836472.98922833CS
12-0.905-25.49295774653.555.291.621285503.64328833CS
26-0.905-25.49295774653.555.291.621285503.64328833CS
52-0.905-25.49295774653.555.291.621285503.64328833CS
156-0.905-25.49295774653.555.291.621285503.64328833CS
260-0.905-25.49295774653.555.291.621285503.64328833CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PSTXPoseida Therapeutics Inc
$ 9.38
(227.97%)
29.42M
IMGCIMG Inc
$ 1.615
(156.35%)
114.46M
IDAIT Stamp Inc
$ 0.364
(102.22%)
549.04M
PGHLPrimega Group Holdings Ltd
$ 20.95
(98.77%)
2.77M
TOYOTOYO Company Ltd
$ 5.41
(86.55%)
48.64M
ALECAlector Inc
$ 2.575
(-34.97%)
7.94M
ABVEAbove Food Ingredients Inc
$ 0.5338
(-34.42%)
1.65M
LGCLLucas GC Ltd
$ 0.7511
(-33.53%)
2.48M
ADDColor Star Technology Company Ltd
$ 4.19
(-31.87%)
204.17k
LESLLeslies Inc
$ 2.445
(-30.34%)
24.38M
IDAIT Stamp Inc
$ 0.364
(102.22%)
560.18M
ELABElevai Labs Inc
$ 0.01255
(-21.07%)
325.82M
NVDANVIDIA Corporation
$ 136.92
(0.66%)
190.3M
RGTIRigetti Computing Inc
$ 2.195
(-20.18%)
126.72M
IMGCIMG Inc
$ 1.615
(156.35%)
114.51M

Your Recent History

Delayed Upgrade Clock